Evidence map›Paper›PMID 39528559›Full record

ArticleScientific reports2024

Oviductal extracellular matrix hydrogels enhance in vitro culture of rabbit embryos and reduce deficiencies during assisted reproductive technologies.

Emilio Francés-Herrero, Laura Lorenzo-Rebenaque, Cristina Casto-Rebollo, José Salvador Vicente, Patricia Sebastian-Leon, Clara Bueno-Fernandez, Adolfo Rodríguez-Eguren, María Gómez-Álvarez, Amparo Faus, Patricia Diaz-Gimeno and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emilio Francés-HerreroDepartment of Pediatrics, Obstetrics and Gynecology, School of Medicine, Universitat de València, 46010, Valencia, Valencia, Spain.
Laura Lorenzo-RebenaqueInstitute for Animal Science and Technology (ICTA), Universitat Politècnica de València, 46022, Valencia, Valencia, Spain.
Cristina Casto-RebolloInstitute for Animal Science and Technology (ICTA), Universitat Politècnica de València, 46022, Valencia, Valencia, Spain.
José Salvador VicenteInstitute for Animal Science and Technology (ICTA), Universitat Politècnica de València, 46022, Valencia, Valencia, Spain.
Patricia Sebastian-LeonIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026, Valencia, Valencia, Spain.
Clara Bueno-FernandezDepartment of Pediatrics, Obstetrics and Gynecology, School of Medicine, Universitat de València, 46010, Valencia, Valencia, Spain.
Adolfo Rodríguez-EgurenIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026, Valencia, Valencia, Spain.
María Gómez-ÁlvarezIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026, Valencia, Valencia, Spain.
Amparo FausIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026, Valencia, Valencia, Spain.
Patricia Diaz-GimenoIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026, Valencia, Valencia, Spain.
Francisco Marco-JiménezInstitute for Animal Science and Technology (ICTA), Universitat Politècnica de València, 46022, Valencia, Valencia, Spain.
Irene CervellóIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026, Valencia, Valencia, Spain. irene.cervello@ivirma.com.ORCID http://orcid.org/0000-0002-7018-4971

Funding

Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana PROMETEO/2018/137Instituto de Salud Carlos III PI17/01039Ministerio de Ciencia, Innovación y Universidades FPU18/06327Ministerio de Ciencia, Innovación y Universidades FPU19/04850Ministerio de Ciencia, Innovación y Universidades FPU20/00251Ministerio de Ciencia, Innovación y Universidades MS21-142
6 · The paper itself

Abstract

In vitro embryo culture often falls short of mimicking the physiological dynamism occurring in the reproductive tract, prompting developmental plasticity in mammalian embryos with consequential genotypic and phenotypic deviations. Recent research highlights the potential of biological derivatives in in vitro culture to mitigate these effects, being the extracellular matrix (ECM) one of the most important components in retaining structural and biological signals derived from the native source tissue. Current bioengineering techniques could provide ECM-based biomaterials mimicking the native environment and offering optimal embryonic development. Rabbit oviducts (n = 24) were decellularized and solubilized to create tissue-specific ECM (OviECM) hydrogels. Following physicochemical characterization, these hydrogels were applied as coatings for the in vitro culture of two-cell embryos over 48 h, along with embryos cultured under In vitro control conditions (n = 218/group), which were subsequently transferred to recipient females. A subset of embryos was recovered on day 6 for transcriptomic analysis (n = 75-80/group), while the remaining embryos were used to assess implantation and birth rates. Rabbit weights were monitored over 20 weeks post-delivery, with blood tests conducted at weeks 8 and 20. Bayesian inference methods were used for statistical analysis. Differences were considered relevant if P ≥ 0.8 (80%). No differences in embryo development and morphology were detected between the OviECM coating and In vitro control conditions. However, embryos cultured on these coatings exhibited upregulation of pathways involved in antigen presentation and immune system activation, as well as, increased cellular response to external stimulus and intracellular protein transport. The implantation and live birth rates were significantly higher in the coating group than in the In vitro control group (30.8% vs. 26.1% and 21.2% vs. 18.1%, respectively). During the first 20 weeks of life, the animals from the coating group showed higher weights than the In vitro control group P0 > 0.8. The animals of both experimental groups showed normal blood parameters. Implementation of OviECM coatings allows for improving in vitro conditions and decreases postnatal phenotypic deviations after assisted reproductive technology (ART). This study could initiate a new embryo culture techniques era to guarantee that ART is utilized in the most efficient and safest possible practice.

Indexed as

Embryo Culture TechniquesExtracellular MatrixHydrogelsAnimalsEmbryo, MammalianEmbryonic DevelopmentEmbryo TransferFallopian TubesFemalePregnancyRabbitsReproductive Techniques, AssistedHydrogelsDecellularizationECM hydrogelEmbryo cultureOviductsPhenotype effect

Identifiers

PMID39528559
PMCPMC11554825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.